<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04069338</url>
  </required_header>
  <id_info>
    <org_study_id>19-619</org_study_id>
    <nct_id>NCT04069338</nct_id>
  </id_info>
  <brief_title>Comparison of Lithotripsy Urolithiasis Machines</brief_title>
  <acronym>CoLUM</acronym>
  <official_title>Randomized Controlled Trial Comparing the Storz Modulith SLX-F2 and Dornier Delta III Lithotripter Machines</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A comparison on the outcomes of patients undergoing shockwave lithotripsy using the Storz&#xD;
      machine versus the Dornier machine.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single institution, prospective randomized controlled clinical trial comparing two&#xD;
      lithotriper machines (the Storz Modulith LX-F2 and Dornier Delta III) in patients who are&#xD;
      undergoing shockwave lithotripsy (SWL) as the primary management of their urinary stone.&#xD;
      Patients record pain score on day of operation and post-operative day 1, and are followed for&#xD;
      1 month until they receive standard of care imaging at 1 month post-operatively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 31, 2019</start_date>
  <completion_date type="Anticipated">October 20, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stone free rate</measure>
    <time_frame>Four weeks post operative</time_frame>
    <description>Presence of stone on follow up imaging</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fluoroscopy time</measure>
    <time_frame>Intra-operative</time_frame>
    <description>Length of fluoroscopy exposure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Time</measure>
    <time_frame>Intra-operative</time_frame>
    <description>Length of surgical procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Scores</measure>
    <time_frame>Four days post-operative</time_frame>
    <description>Response to visual analog scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication Rates</measure>
    <time_frame>One month post-operative</time_frame>
    <description>Medical complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Interventions required</measure>
    <time_frame>One month post-operative</time_frame>
    <description>Follow up surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">162</enrollment>
  <condition>Kidney Stone</condition>
  <condition>Kidney Calculi</condition>
  <condition>Ureteral Calculi</condition>
  <condition>Ureterolithiasis</condition>
  <condition>Urolithiasis</condition>
  <arm_group>
    <arm_group_label>Device Storz Modulith SLX-F2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive standard of care treatment for their urolithiasis using the Device Storz Modulith SLX-F2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dornier Delta III Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive standard of care treatment for their urolithiasis using the Dornier Delta III lithotripter</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lithotripter</intervention_name>
    <description>Patients receive standard of care treatment for their urolithiasis using one of two lithotripter machines</description>
    <arm_group_label>Device Storz Modulith SLX-F2</arm_group_label>
    <arm_group_label>Dornier Delta III Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Cleveland Clinic Foundation patients planned for elective SWL with a preoperative CT&#xD;
        performed&#xD;
&#xD;
          -  Age â‰¥ 18 years old&#xD;
&#xD;
          -  Male and female patients&#xD;
&#xD;
          -  Patients of all ethnic backgrounds&#xD;
&#xD;
          -  Stone size 5-15mm&#xD;
&#xD;
          -  Stone location: Renal or proximal ureter&#xD;
&#xD;
          -  Stone density: &lt; 1200 Hounsfield Units&#xD;
&#xD;
          -  Skin to stone distance: &lt; 12cm&#xD;
&#xD;
          -  Primary treatment for a solitary stone (must be previously untreated)&#xD;
&#xD;
        Patients must be capable of giving informed consent and must be capable and willing to&#xD;
        enroll and participate fully with the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior treatment for specified stone&#xD;
&#xD;
               -  Multiple stones on treatment side (even if only one is treated)&#xD;
&#xD;
               -  Anticoagulated or history of coagulopathy&#xD;
&#xD;
               -  Prior ureteral stent placement&#xD;
&#xD;
               -  Technical problems/impossibility of localizing the stone on the day of&#xD;
                  intervention&#xD;
&#xD;
        Patients unable to give informed consent or unwilling to enroll or participate in the study&#xD;
        will be excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manoj Monga, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manoj Monga, MD</last_name>
    <phone>216 445-8678</phone>
    <email>mongam@ccf.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Naveen Kachroo, MD</last_name>
    <phone>216-973-5227</phone>
    <email>kachron@ccf.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manoj Monga, MD</last_name>
      <phone>216-445-8678</phone>
      <email>mongam@ccf.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>August 23, 2019</study_first_submitted>
  <study_first_submitted_qc>August 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2019</study_first_posted>
  <last_update_submitted>May 19, 2021</last_update_submitted>
  <last_update_submitted_qc>May 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lithotripsy</keyword>
  <keyword>Extracorporeal shockwave lithotripsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Urolithiasis</mesh_term>
    <mesh_term>Urinary Calculi</mesh_term>
    <mesh_term>Ureteral Calculi</mesh_term>
    <mesh_term>Ureterolithiasis</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

